Andrada Mining acquisition elevates the miner to emerging mid-tier status. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSKP.L Regulatory News (SKP)

  • There is currently no data for SKP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Rule 8.3- Skyepharma PLC

6 Jan 2006 13:15

Fidelity International Ltd06 January 2006 FORM 8.3 DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE (Rule 8.3 of the City Code on Takeovers and Mergers) 1. KEY INFORMATION Name of person dealing (Note 1) FMR CORP AND/OR ONE OR MORE OF ITS DIRECT OR INDIRECT SUBSIDIARIES AND FIDELITY INTERNATIONAL LIMITED AND/OR ONE OR MORE OF ITS DIRECT AND INDIRECT SUBSIDIARIES Company dealt in SKYEPHARMA PLC Class of relevant securityto which the dealings being disclosed relate (Note 2) ORDINARY SHARES Date of dealing 5 JANUARY 2006 2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE (a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3) Long Short Number (%) Number (%) (1) Relevant securities 76,079,275 (10.09%)(2) Derivatives (other than options) (3) Options and agreements to purchase/sell Total 76,079,275 (10.09%) (b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3) Class of relevant security: Long Short Number (%) Number (%) (1) Relevant securities (2) Derivatives (other than options) (3) Options and agreements to purchase/sell Total (c) Rights to subscribe (Note 3) Class of relevant security: Details 3. DEALINGS (Note 4) (a) Purchases and sales Purchase/sale Number of securities Price per unit (Note 5) SELL 362,364 0.4769 GBP/SHARE (b) Derivatives transactions (other than options) Product name, Long/short Number of securities Price per unit e.g. CFD (Note 6) (Note 7) (Note 5) (c) Options transactions in respect of existing securities(i) Writing, selling, purchasing or varying Product Writing, Number of Exercise Type, e.g. Expiry Option moneyname, selling, securities price American, date paid/e.g. purchasing, to which European received call varying etc. the option etc. per unit option relates (Note 5) (Note 7) (ii) Exercising Product name, e.g. Number of securities Exercise price per unit call option (Note 5) (d) Other dealings (including new securities)(Note 4) Nature of transaction Details Price per unit (Note 8) (if applicable) (Note 5) 4. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives Full details of any agreement, arrangement or understanding between the persondisclosing and any other person relating to the voting rights of any relevantsecurities under any option referred to on this form or relating to the votingrights or future acquisition or disposal of any relevant securities to which anyderivative referred to on this form is referenced. If none, this should bestated. Is a Supplemental Form 8 attached? (Note 9) NO Date of disclosure 06 JANUARY 2006 Contact name LAURA COTTERELL Telephone number 01737 837148 If a connected EFM, name of offeree/offeror with which connected N/A If a connected EFM, state nature of connection (Note 10) N/A Notes The Notes on Form 8.3 can be viewed on the Takeover Panel's website atwww.thetakeoverpanel.org.uk This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
22nd Apr 20169:29 amRNSForm 8.5 (EPT/RI)
21st Apr 20162:49 pmRNSForm 8.3 - [Skyepharma plc]
21st Apr 20162:41 pmRNSForm 8.3 - Skyepharma
21st Apr 20162:11 pmRNSForm 8.3 - Vectura Group Plc
21st Apr 20161:54 pmRNSForm 8.3 - Skyepharma plc
21st Apr 20161:28 pmRNSForm 8.3 - Skyepharma PLC
21st Apr 201611:24 amPRNForm 8.3 - Skyepharma Plc
21st Apr 20169:46 amBUSForm 8.3 - Skyepharma Plc
21st Apr 20169:29 amRNSForm 8.5 (EPT/RI) - Vectura Group PLC
21st Apr 20169:24 amRNSForm 8.5 (EPT/RI) - Skyepharma Plc
21st Apr 20168:57 amRNSForm 8.5 (EPT/RI) - Skyepharma Plc
20th Apr 20162:58 pmRNSForm 8.3 - Skyepharma Plc
20th Apr 20161:53 pmRNSForm 8.3 - [Skyepharma plc]
20th Apr 201612:43 pmRNSForm 8.3 - Skyepharma plc
20th Apr 201611:22 amPRNForm 8.3 - Skyepharma Plc
20th Apr 201610:40 amRNSForm 8.5 (EPT/RI) - Skyepharma PLC
20th Apr 201610:19 amRNSForm 8.5 (EPT/RI) - Skyepharma Plc
20th Apr 20169:38 amBUSForm 8.3 - Skyepharma Plc
19th Apr 20162:15 pmRNSForm 8.3 - [Skyepharma plc]
19th Apr 201610:41 amRNSForm 8.5 (EPT/RI) - Skyepharma PLC
19th Apr 201610:36 amPRNForm 8.3 - Skyepharma Plc
19th Apr 20169:16 amRNSForm 8.5 (EPT/RI) - Skyepharma Plc
18th Apr 201611:46 amRNSForm 8.5 (EPT/RI) - Skyepharma Plc
18th Apr 201611:21 amRNSForm 8.5 (EPT/RI) - Skyepharma Plc
18th Apr 201611:08 amRNSForm 8.5 (EPT/RI) - Vectura Group PLC
18th Apr 201610:19 amRNSForm 8.5 (EPT/RI) - Skyepharma PLC
15th Apr 20163:06 pmRNSForm 8.5 (EPT/RI) - Vectura Group PLC REPLACEMENT
15th Apr 20163:00 pmRNSForm 8.3 - Skyepharma PLC
15th Apr 20162:41 pmRNSForm 8.5 (EPT/RI) - Vectura Group PLC REPLACEMENT
15th Apr 20161:25 pmRNSForm 8.3 - [Skyepharma plc]
15th Apr 201611:59 amRNSForm 8.5 (EPT/RI) - Vectura Group PLC
15th Apr 201611:05 amBUSForm 8.3 - Skyepharma
15th Apr 201611:04 amRNSForm 8.5 (EPT/RI) - Skyepharma PLC
15th Apr 201610:38 amRNSForm 8.5 (EPT/RI) - Skypharma Plc
14th Apr 20165:00 pmRNSForm 8 (OPD) Amendment
14th Apr 20161:42 pmRNSForm 8.5 (EPT/RI) - Vectura Group PLC
14th Apr 20161:39 pmRNSForm 8.5 (EPT/RI) - Skyepharma Plc
14th Apr 201612:45 pmRNSForm 8.3 - Skyepharma PLC
14th Apr 201612:34 pmRNSForm 8.3 - [Skyepharma plc]
14th Apr 201611:34 amRNSForm 8.5 (EPT/RI) - Skyepharma Plc
14th Apr 201611:29 amRNSForm 8.5 (EPT/RI)
13th Apr 20162:50 pmRNSForm 8.3 - Skyepharma plc
13th Apr 20162:29 pmRNSForm 8.3 - Skyepharma PLC
13th Apr 20162:23 pmRNSForm 8.3 - Vectura Group Plc
13th Apr 20162:05 pmRNSForm 8.3 - Skyepharma Plc
13th Apr 201611:59 amRNSForm 8.5 (EPT/RI) - Vectura Group PLC
13th Apr 201611:59 amRNSForm 8.5 (EPT/RI) - Skyepharma PLC
13th Apr 201611:18 amRNSForm 8.5 (EPT/RI) - Skypharma Plc
13th Apr 201610:51 amRNSForm 8.5 (EPT/RI) - Skypharma Plc
13th Apr 201610:01 amRNSForm 8.5 (EPT/RI) - Skyepharma PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.